These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

774 related items for PubMed ID: 19622121

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM.
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Videocapillaroscopy in the differential diagnosis between psoriasis and seborrheic dermatitis of the scalp.
    Rosina P, Zamperetti MR, Giovannini A, Girolomoni G.
    Dermatology; 2007; 214(1):21-4. PubMed ID: 17191043
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone.
    Augustin M, Peeters P, Radtke M, Moehling U, Lapp C.
    Dermatology; 2007 Jun; 215(3):219-28. PubMed ID: 17823519
    [Abstract] [Full Text] [Related]

  • 10. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
    Rigopoulos D, Gregoriou S, Daniel Iii CR, Belyayeva H, Larios G, Verra P, Stamou C, Kontochristopoulos G, Avgerinou G, Katsambas A.
    Dermatology; 2009 Jun; 218(4):338-41. PubMed ID: 19212110
    [Abstract] [Full Text] [Related]

  • 11. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
    Saraceno R, Andreassi L, Ayala F, Bongiorno MR, Giannetti A, Lisi P, Martini P, Peris K, Peserico A, Chimenti S.
    J Dermatolog Treat; 2007 Jun; 18(6):361-5. PubMed ID: 17934937
    [Abstract] [Full Text] [Related]

  • 12. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L.
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S.
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [Abstract] [Full Text] [Related]

  • 15. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C, Ganslandt C, Guenther L, Johannesson A, Buckley C, Simon JC, Stegmann H, Vestergaard Tingleff L.
    Eur J Dermatol; 2010 Aug; 20(4):465-71. PubMed ID: 20413372
    [Abstract] [Full Text] [Related]

  • 16. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C, Hoffmann V, Shapiro J, Saari S, Cambazard F, Milsgaard M.
    Dermatology; 2008 Aug; 217(2):107-13. PubMed ID: 18463448
    [Abstract] [Full Text] [Related]

  • 17. Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.
    Singh S, Reddy DC, Pandey SS.
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):61-5. PubMed ID: 10863225
    [Abstract] [Full Text] [Related]

  • 18. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
    Kumaran MS, Kaur I, Kumar B.
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study.
    Erceg A, Bovenschen HJ, van de Kerkhof PC, Seyger MM.
    Br J Dermatol; 2006 Jul; 155(1):110-4. PubMed ID: 16792761
    [Abstract] [Full Text] [Related]

  • 20. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A, Sommer A, Hyun J, Bräutigam M, Brockmeyer NH, Altmeyer P, Gambichler T.
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.